What Patients wih DLBCL Should Know About Monjuvi



Generic Name: Tafasitamab

Company: Morphosis/Incyte

Approval Status: Approved

Drug Class: Targeted Therapy Medicines

General Information:

Monjuvi contains an active salt known,n as Tafasitamab. The medicinal product is an engineered antibody that is designed to bind to the CD19 protein on B-cells that progress in an uncontrolled way in leukemia and lymphoma.

According to a study named L-MIND 55% of individuals with relapsed/refractory (RR) diffuse large B-cell lymphoma (DLBCL) who received Monjuvi in combination with Lenalidomide followed by Lenalidomide alone experienced remission, including 37 percent with complete responses (CR). The median time span of response was 21.7 months. Monjuvi 200 mg injection (tafasitamab-cxix) was initially approved in July 2020.

Indication/Uses of Monjuvi:

The medicine Monjuvi is a CD-19-directed monoclonal antibody approved by the FDA for the treatment of relapsed/refractory diffuse large B-cell lymphoma (RR DLBCL) in combination with a medicine named lenalidomide (Revlimid). 

Monjuvi Dosage Information:

The proposed dosage of Tafasitamab monjuvi injection is administered as an intravenous (IV) infusion in combination with the medicine lenalidomide (Revlimid) for up to 12 cycles followed by Monjuvi alone until disease progression or unacceptable adverse reactions.

Adverse Reactions of Monjuvi:

The common adverse reactions include fever, fatigue, diarrhea, edema, respiratory infections, and cough. Monjuvi can be responsible for causing the depletion of RBCs (anemia), WBCs (neutropenia), and Platelets (thrombocytopenia), which can be responsible for infection and easy bleeding.

More serious adverse reactions may include infusion reactions and serious blood cell deficiencies. The medicine causes fetal harm when used during pregnancy.

Where To Buy Monjuvi:

You can buy Monjuvi online in Noida, India from THE INDIAN PHARMA (TIP) if the medicine has not been approved or is not available in your home country. We can help you to get/access quality, affordable and assured delivery of hard-to-access prescription medications for certain Blood Cancer. At TIP, we can help you to get Monjuvi (tafasitamab-cxix) 200 mg for injection for intravenous use at the lowest cost. Please contact at TOLL-FREE: 1800-889-1064 or Call/Whatsapp: +919310090915 to find Monjuvi injection price in India. At TIP, you can get FDA-approved medicines in Delhi, Australia, New Zealand, Singapore, Turkey, Switzerland, UAE, Dubai, Pakistan, Bangladesh, Sri Lanka, Japan, Russia, and other major locations across the world.

Reference:

https://www.monjuvi.com/

Comments

Post a Comment

Popular posts from this blog

Buy Trodelvy sacituzumab govitecan-hziy in India

  Trodelvy Overview: Trodelvy is widely prescribed by Oncologists for the treatment of patients with HR+/HER2- Metastatic Breast Cancer, Metastatic Triple-Negative Breast Cancer (mTNBC), and Metastatic Urothelial Cancer (mUC). It is considered a promising treatment option for those who are not ideal candidates for some conventional therapies. Developed by Immunomedics, Trodelvy 180 mg and Trodelvy 200 mg are two available commercial strengths. Worldwide, Trodelvy is promoted and facilitated by Gilead Sciences. Trodelvy is first approved on 22 April 2020. It is given by intravenous (IV) infusion by a health specialist. The medication received its (European Medicines Agency) EMA approval in October 2021. Trodelvy 180 mg and 200 mg injections are yet to be approved in India. The cost of Trodelvy in India usually depends on international factors. Buy Trodelvy from a Reliable Source: Many suppliers who are not authorized to handle or supply life-saving medicines such as Trodelvy found ...
Read more

Lenvatinib Medication Guide

Lenvatinib is recommended for treating patients with locally recurrent, progressive, metastatic, radioactive iodine-refractory differentiated thyroid cancer (RAI-refractory DTC), together with everolimus for advanced renal cell carcinoma and for hepatocellular carcinoma.  Here are a few important points for patients before taking Lenvatinib:- Female patients who are able to become pregnant must use an effective method of birth control while on the treatment with lenvatinib and for at least 2 weeks after its last dose. Discuss with your doctor about the birth control methods you can use during this time. Lenvatinib is taken at the same time each and every day. If a patient misses any dose, and it cannot be consumed within 12 hours, then that dose must be skipped and the next dose should be consumed at the usual time of administration. The recommended dose is lenvatinib 24 mg (two lenvatinib 10 mg capsules and one lenvatinib 4 mg capsule) orally, taken once in a day, either with or...
Read more

Difference Between Multiple Myeloma And Leukemia

Image
What is multiple myeloma:  This is also known as plasma cell myeloma or Kahler's disease. It is a cancer in plasma cells that typically produce antibodies. When there is only one tumor present it is called as plasmacytoma and when more than one then called as multiple myeloma. The main cause of myeloma is unknown but the major risk factors are obesity,  inheritance chemicals, radiation, etc. With the effect of cancer, there is an abnormality in plasma cells that produces abnormal antibodies that can cause kidney problems. At the initial stage, there is no sign and symptoms but with the advancement of time bone pain, bleeding, anemia and frequent infections are the common symptoms. Multiple myeloma is diagnosed with the help of blood or urine tests or bone marrow biopsy. And the medication of multiple myeloma includes: Chemotherapy- There are several drugs that are used in the treatment of multiple myeloma such as doxorubicin, etoposide, cisplatin, cyclophosphami...
Read more